CBHA
Alternative Names: M-carboxycinnamic acid bishydroxamideLatest Information Update: 29 Apr 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics
- Mechanism of Action Apoptosis stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Neuroblastoma
Most Recent Events
- 02 Dec 1999 New profile
- 02 Dec 1999 Preclinical development for Neuroblastoma in USA (Unknown route)